Cellular Modeling Systems for Gene Regulation Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current approaches in molecular biology and genetics have not effectively translated into sustained success for gene therapy or control of genetic processes, particularly in addressing complex diseases like cardiovascular disease, despite advances in diagnostics and interventional cardiology, due to a lack of understanding of key regulatory pathways and target molecules.
Innovation Solution
A systems biology approach combining network biology, genomic, proteomic, metabolomic, and bioinformatics tools to develop cellular modeling systems that probe disease processes, using AI-based informatics platforms like REFS to identify modulators and drug targets through high-throughput biological readouts and bioinformatic analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional molecular biology and genetics approaches are used, then detailed measurement of gene regulation is achieved, but sustained success in gene therapy and control of genetic processes is not realized
Solution Approach 1:
The patent segments the complex biological system into multiple cell types (cardiomyocytes, fibroblasts, endothelial cells, smooth muscle cells) and analyzes each separately to understand their specific contributions to disease pathology, enabling more targeted and reliable therapeutic interventions
Solution Approach 2:
The patent uses an AI-based informatics platform as an intermediary to integrate and analyze data from multiple omics layers (genomic, transcriptomic, proteomic, metabolomic) and connect molecular findings to clinical outcomes, bridging the gap between basic research and therapeutic success
2Productivity
If genomic sequencing and molecular biology tools are applied, then rapid and precise measurement capabilities are achieved, but understanding of key regulatory pathways and target molecules remains insufficient
Solution Approach 1:
The patent merges multiple data types and analytical approaches (genomics, transcriptomics, proteomics, metabolomics, AI-based informatics) into a unified systems biology framework that preserves and integrates information across all levels of biological organization to reveal regulatory pathways
Solution Approach 2:
The patent develops a universal AI-based informatics platform that can analyze diverse biological data types and apply across multiple disease contexts, enabling the tool to serve multiple functions from data integration to pathway analysis to drug target identification
3Reliability
If diagnostics and interventional cardiology techniques are advanced, then disease management effectiveness is improved, but etiology understanding and identification of drugable targets remain incomplete
Solution Approach 1:
The patent adds a new dimension of analysis by integrating multi-omics data with AI-based informatics, moving beyond traditional single-omics or clinical-only approaches to create a comprehensive view that reveals etiological mechanisms and identifies novel drugable targets
Data Source
AI summary
Described herein is a discovery Platform Technology for analyzing a biological system or process (e.g., a disease condition, such as cancer) via model building,